Technical Analysis for BLPH - Bellerophon Therapeutics, Inc.

Grade Last Price % Change Price Change
F 3.99 1.27% 0.05
BLPH closed up 2.87 percent on Friday, May 14, 2021, on 44 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical BLPH trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction 1.27%
Oversold Stochastic Weakness 1.27%
New 52 Week Closing Low Bearish 4.18%
New 52 Week Low Weakness 4.18%
Below Lower BB Weakness 4.18%
Down 3 Days in a Row Weakness 4.18%
Lower Bollinger Band Touch Weakness 4.18%
Oversold Stochastic Weakness 4.18%
New 52 Week Closing Low Bearish 0.25%
New 52 Week Low Weakness 0.25%
Older End-of-Day Signals for BLPH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High about 1 hour ago
10 DMA Resistance about 1 hour ago
Up 3% about 1 hour ago
Up 2% about 1 hour ago
Up 1% about 2 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bellerophon Therapeutics LLC, a clinical-stage therapeutics company, focuses on the development of various products for the treatment of cardiopulmonary and cardiac diseases. Its product candidates include INOpulse for the treatment of pulmonary arterial hypertension, as well as to treat pulmonary hypertension associated with chronic obstructive pulmonary diseases; and bioabsorbable cardiac matrix, a medical device for the prevention of congestive heart failure. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics LLC in January 2014. Bellerophon Therapeutics LLC was founded in 2009 and is based in Hampton, New Jersey.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Hypertension Heart Failure Anatomy Pulmonary Disease Cardiovascular Diseases Chronic Obstructive Pulmonary Disease Pulmonary Arterial Hypertension Respiratory Disease Aging Associated Diseases Pulmonology Pulmonary Hypertension Cardiovascular System Oab Chronic Obstructive Pulmonary Diseases Congestive Heart Failure Cardiac Diseases

Is BLPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.07
52 Week Low 3.8
Average Volume 73,121
200-Day Moving Average 7.88
50-Day Moving Average 5.10
20-Day Moving Average 4.28
10-Day Moving Average 4.07
Average True Range 0.25
ADX 33.54
+DI 8.37
-DI 26.06
Chandelier Exit (Long, 3 ATRs ) 4.22
Chandelier Exit (Short, 3 ATRs ) 4.56
Upper Bollinger Band 4.78
Lower Bollinger Band 3.78
Percent B (%b) 0.16
BandWidth 23.37
MACD Line -0.33
MACD Signal Line -0.34
MACD Histogram 0.0163
Fundamentals Value
Market Cap 37.42 Million
Num Shares 9.5 Million
EPS 0.09
Price-to-Earnings (P/E) Ratio 46.35
Price-to-Sales 0.00
Price-to-Book 1.41
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.17
Resistance 3 (R3) 4.16 4.07 4.13
Resistance 2 (R2) 4.07 4.02 4.08 4.11
Resistance 1 (R1) 4.01 3.98 4.04 4.02 4.10
Pivot Point 3.92 3.92 3.94 3.93 3.92
Support 1 (S1) 3.86 3.87 3.89 3.87 3.78
Support 2 (S2) 3.77 3.83 3.78 3.77
Support 3 (S3) 3.71 3.77 3.75
Support 4 (S4) 3.72